Group 1 - Dyne Therapeutics, Inc. announced a public offering of 24,242,425 shares of common stock at a price of $8.25 per share, aiming for gross proceeds of $200 million before expenses [1] - The offering is expected to close around July 2, 2025, pending customary closing conditions [1] - Dyne has granted underwriters a 30-day option to purchase an additional 3,636,363 shares at the public offering price [1] Group 2 - The offering is conducted under a shelf registration statement filed with the SEC on March 5, 2024, which became effective upon filing [3] - A preliminary prospectus supplement has been filed with the SEC, and a final prospectus will also be filed [3] Group 3 - Dyne Therapeutics focuses on developing therapeutics for genetically driven neuromuscular diseases, including myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) [5] - The company is also advancing preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease [5]

Core Viewpoint - TAT Technologies Ltd. has successfully completed an underwritten public offering of 4,150,000 ordinary shares, with an additional 622,500 shares purchased by underwriters, raising a total of $6.3 million for general corporate purposes [1][2]. Group 1: Offering Details - The offering consisted of 1,625,000 ordinary shares sold and issued by TAT and 2,525,000 ordinary shares sold by selling shareholders [1]. - The underwriters exercised their option to purchase an additional 622,500 ordinary shares at a public offering price of $26.00 per share, the same as the initial offering price [1]. - The total gross proceeds from the sale of the Option Shares to TAT was $6.3 million, which will be used for general corporate purposes, including working capital and capital expenditures [2]. Group 2: Management and Regulatory Information - Stifel, Nicolaus & Company, Incorporated and Truist Securities, Inc. acted as joint book-running managers for the offering, with additional support from The Benchmark Company, LLC and Lake Street Capital Markets, LLC [3]. - A registration statement on Form F-3 related to the ordinary shares sold in the offering has been filed with the U.S. Securities and Exchange Commission and was declared effective on April 25, 2025 [4]. Group 3: Company Overview - TAT Technologies Ltd. is a leading provider of solutions and services to the aerospace and defense industries, operating four operational units focused on OEM and MRO services for heat transfer solutions and aviation components [6].

Core Viewpoint - Globavend Holdings Limited is conducting a public offering to raise approximately $15 million to support its e-commerce logistics operations and future growth initiatives [1][4]. Group 1: Offering Details - The offering consists of 21,739,130 ordinary shares or pre-funded warrants, each sold with one Series A Warrant and one Series B Warrant [2]. - The purchase price for each ordinary share and accompanying warrants is set at $0.69, while the pre-funded warrants are priced slightly lower [3]. - The Series A Warrants have an initial exercise price of $0.69 and expire one year after their initial exercise date, while the Series B Warrants have an exercise price of $1.173 and also expire one year after their initial exercise date [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for capital expenditures, increasing operating capacity, working capital, general corporate purposes, purchasing warehouses, and potential mergers and acquisitions [4]. Group 3: Company Overview - Globavend Holdings Limited is an emerging e-commerce logistics provider offering end-to-end logistics solutions primarily in Hong Kong, Australia, and New Zealand [6]. - The company serves enterprise customers, facilitating business-to-consumer (B2C) transactions and providing integrated cross-border logistics services [6].

Core Viewpoint - Allot Ltd. is conducting a public offering of 5,000,000 ordinary shares priced at $8.00 per share, with an additional option for underwriters to purchase up to 750,000 shares [1][2]. Group 1: Offering Details - The gross proceeds from the offering are expected to be $40.0 million, assuming no exercise of the underwriters' option [2]. - The net proceeds will be used to repay $31.41 million of principal outstanding under the Lynrock Note and the remainder for general corporate purposes [2][3]. - The offering is expected to close on June 26, 2025, subject to customary closing conditions [1]. Group 2: Lynrock Note Conversion - Lynrock has agreed to convert the remaining $8.59 million of principal under the Lynrock Note into 1,249,995 ordinary shares [3]. - Following the repayment and conversion of the Lynrock Note, the company will have no outstanding indebtedness for borrowed money [3]. Group 3: Underwriters and Registration - TD Cowen and William Blair are acting as joint book-running managers, with Needham & Company as lead manager and Northland Capital Markets as co-manager for the offering [4]. - The public offering is made pursuant to an effective shelf registration statement filed with the SEC [5].

Core Viewpoint - Allot Ltd. announced a proposed public offering of its ordinary shares, with all shares being sold by the Company [1]. Group 1: Use of Proceeds - The net proceeds from the public offering are expected to be used to repay $31.41 million of principal outstanding under the Lynrock Note, which has a face value of $40 million, and the remaining balance will be allocated for general corporate purposes [2]. - Lynrock has agreed to convert the remaining $8.59 million of principal outstanding under the Lynrock Note into ordinary shares, and will enter into a lock-up agreement for 75 days following the final prospectus supplement [3]. Group 2: Offering Details - The Company plans to grant underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares sold in the public offering at the public offering price, less underwriting discounts and commissions [4]. - The public offering is being made under an effective shelf registration statement on Form F-3 filed with the SEC, declared effective on April 3, 2025 [5]. Group 3: Company Overview - Allot Ltd. is recognized as a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide [7].

Company Overview - QMMM Holdings Limited is a digital media advertising, virtual avatar, and virtual apparel technology service provider based in Hong Kong [1] - The company has over 18 years of industry experience and has executed more than 500 commercial campaigns using interactive design, animation, art-tech, and virtual technologies [4] - QMMM has collaborated with various sectors including large domestic and international banks, real estate developers, amusement parks, athletic apparel brands, and luxury cosmetic brands [4] Recent Financial Activity - QMMM Holdings Limited announced the closing of a public offering of 40,000,000 ordinary shares at a price of $0.20 per share, resulting in gross proceeds of approximately $8 million before expenses [1][2] - The offering was facilitated by Pacific Century Securities LLC and Revere Securities LLC as co-placement agents [2] Regulatory Information - The securities were offered under a registration statement on Form F-1, which was filed with the U.S. Securities and Exchange Commission on May 8, 2025, and declared effective on June 20, 2025 [2]

Company Overview - Palatin Technologies, Inc. is a biopharmaceutical company focused on developing first-in-class medicines that modulate the melanocortin receptor system [6] - The company aims to address diseases with significant unmet medical needs and commercial potential through targeted, receptor-specific product candidates [6] Recent Offering - The company announced the closing of a public offering consisting of 7,324,119 shares of common stock and accompanying warrants at a combined public offering price of $0.15 per share [1] - The offering generated approximately $1.1 million in gross proceeds, which will primarily be used for working capital and general corporate purposes [3] Warrants Details - The Series F Warrants have an exercise price of $0.30 per share, are immediately exercisable, and expire five years from the issuance date [2] - The Series G Warrants have an exercise price of $0.15 per share, are immediately exercisable, and expire either 24 months from the issuance date or at the end of the FDA Exercise Period [2] - The Series H Warrants will be issued upon the exercise of the Series G Warrants, with an exercise price of $0.225 per share and expiring 24 months after issuance [2] Placement Agents - A.G.P./Alliance Global Partners acted as the lead placement agent, while Laidlaw & Company (UK) Ltd. served as the co-placement agent for the offering [3]

Core Viewpoint - Pineapple Financial Inc. has announced a public offering of 10,000,000 units at a price of $0.15 per unit, each unit consisting of one share of common stock and one warrant to purchase an additional share [1][2]. Group 1: Offering Details - The offering is expected to close on or about May 5, 2025, subject to customary closing conditions [2]. - D. Boral Capital LLC is acting as the Exclusive Placement Agent for the offering [2]. - The offering is conducted under the Company's registration statement on Form S-1, which was declared effective by the SEC on May 1, 2025 [3]. Group 2: Company Overview - Pineapple Financial Inc. is a leading Canadian mortgage technology and brokerage firm focused on enhancing the mortgage process for brokers, lenders, and clients [5]. - The company provides advanced tools, marketing automation, analytics, and proprietary technology aimed at simplifying the mortgage experience [5]. - Pineapple is committed to innovation and aims to set a new standard for excellence in the mortgage industry [5].

Core Viewpoint - Draganfly Inc. has initiated an underwritten public offering in the United States, which includes units of common shares and warrants to purchase common shares, subject to market conditions [1][3]. Group 1: Offering Details - The offering is managed by Maxim Group LLC as the sole book-running manager [2]. - The net proceeds from the offering will be used for general corporate purposes, including funding new product capabilities, growth initiatives, working capital, and ongoing development and marketing of core products [2]. - The offering is contingent upon customary closing conditions, including necessary regulatory approvals from the Canadian Securities Exchange and The Nasdaq Stock Market [3]. Group 2: Regulatory and Legal Framework - The offering is made under an effective shelf registration statement on Form F-10, previously filed with the U.S. Securities and Exchange Commission (SEC) [4]. - A preliminary prospectus supplement will be filed with applicable securities commissions in Canada and the SEC, detailing the terms of the offering [5]. Group 3: Company Background - Draganfly Inc. is a pioneer in drone solutions, AI-driven software, and robotics, with over 25 years of innovation in the drone technology sector [7]. - The company provides solutions for various sectors, including public safety, agriculture, industrial inspections, security, mapping, and surveying [7].